Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning
- PMID: 26891837
- DOI: 10.1007/s10822-016-9903-6
Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning
Abstract
Chagas disease is a parasitic infection caused by the protozoa Trypanosoma cruzi that affects about 6 million people in Latin America. Despite its sanitary importance, there are currently only two drugs available for treatment: benznidazole and nifurtimox, both exhibiting serious adverse effects and limited efficacy in the chronic stage of the disease. Polyamines are ubiquitous to all living organisms where they participate in multiple basic functions such as biosynthesis of nucleic acids and proteins, proliferation and cell differentiation. T. cruzi is auxotroph for polyamines, which are taken up from the extracellular medium by efficient transporters and, to a large extent, incorporated into trypanothione (bis-glutathionylspermidine), the major redox cosubstrate of trypanosomatids. From a 268-compound database containing polyamine analogs with and without inhibitory effect on T. cruzi we have inferred classificatory models that were later applied in a virtual screening campaign to identify anti-trypanosomal compounds among drugs already used for other therapeutic indications (i.e. computer-guided drug repositioning) compiled in the DrugBank and Sweetlead databases. Five of the candidates identified with this strategy were evaluated in cellular models from different pathogenic trypanosomatids (T. cruzi wt, T. cruzi PAT12, T. brucei and Leishmania infantum), and in vitro models of aminoacid/polyamine transport assays and trypanothione synthetase inhibition assay. Triclabendazole, sertaconazole and paroxetine displayed inhibitory effects on the proliferation of T. cruzi (epimastigotes) and the uptake of putrescine by the parasite. They also interfered with the uptake of others aminoacids and the proliferation of infective T. brucei and L. infantum (promastigotes). Trypanothione synthetase was ruled out as molecular target for the anti-parasitic activity of these compounds.
Keywords: Chagas disease; Drug repositioning; Paroxetine; Polyamines; Triclabendazole; Trypanosomatids virtual screening.
Similar articles
-
Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.Exp Parasitol. 2016 Dec;171:23-32. doi: 10.1016/j.exppara.2016.10.007. Epub 2016 Oct 8. Exp Parasitol. 2016. PMID: 27729250
-
Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.PLoS Negl Trop Dis. 2016 Apr 12;10(4):e0004617. doi: 10.1371/journal.pntd.0004617. eCollection 2016 Apr. PLoS Negl Trop Dis. 2016. PMID: 27070550 Free PMC article.
-
Bis(glutathionyl)spermine and other novel trypanothione analogues in Trypanosoma cruzi.J Biol Chem. 2003 Jul 25;278(30):27612-9. doi: 10.1074/jbc.M302750200. Epub 2003 May 15. J Biol Chem. 2003. PMID: 12750367
-
Chagas disease: progress and new perspectives.Curr Med Chem. 2010;17(5):423-52. doi: 10.2174/092986710790226101. Curr Med Chem. 2010. PMID: 20015038 Review.
-
The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies.Curr Med Chem. 2019;26(36):6614-6635. doi: 10.2174/0929867325666180926151059. Curr Med Chem. 2019. PMID: 30259812 Review.
Cited by
-
Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design.Pharmaceuticals (Basel). 2023 Mar 10;16(3):428. doi: 10.3390/ph16030428. Pharmaceuticals (Basel). 2023. PMID: 36986527 Free PMC article.
-
Heterocyclic Antidepressants with Antimicrobial and Fungicide Activity.Molecules. 2025 Feb 27;30(5):1102. doi: 10.3390/molecules30051102. Molecules. 2025. PMID: 40076325 Free PMC article. Review.
-
Current trends in the pharmacological management of Chagas disease.Int J Parasitol Drugs Drug Resist. 2020 Apr;12:7-17. doi: 10.1016/j.ijpddr.2019.11.004. Epub 2019 Dec 10. Int J Parasitol Drugs Drug Resist. 2020. PMID: 31862616 Free PMC article. Review.
-
Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii.Parasitol Res. 2023 Dec 23;123(1):69. doi: 10.1007/s00436-023-08062-4. Parasitol Res. 2023. PMID: 38135783
-
Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities.J Pharm Anal. 2025 Jan;15(1):101084. doi: 10.1016/j.jpha.2024.101084. Epub 2024 Aug 27. J Pharm Anal. 2025. PMID: 39896318 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous